Biotech

All Articles

Vaccine and also Keytruda combination efficient in squamous cell carcinoma

.Invulnerable checkpoint inhibitors are the superheroes of cancer treatment. Medications like Bristo...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of notable leadership hirings, firings and re...

Regeneron's Opdualag opponent reveals 57% feedback fee

.Regeneron is actually back along with long-term follow-up for its LAG-3 inhibitor and PD-1 preventi...

AstraZeneca posts records on in-house competitors to AbbVie, Pfizer ADCs

.AstraZeneca has actually shared a very early consider the efficiency of its internal antibody-drug ...

iTeos- GSK's TIGIT superstar reveals meaningful remodeling

.After declaring a stage 3 launch based on beneficial midstage outcomes, iTeos and GSK are finally d...

More collective FDA can easily increase unusual ailment R&ampD: document

.The FDA ought to be actually extra available and collective to unleash a surge in approvals of unco...

Zenas, MBX, Bicara head to Nasdaq in warm time for biotech IPOs

.It is actually an uncommonly hectic Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara T...

Atea's COVID antiviral neglects to halt hospitalizations in stage 3

.Atea Pharmaceuticals' antiviral has actually stopped working one more COVID-19 trial, however the b...

Neurocrine's offer to conserve mental illness prospect falls short

.Neurocrine Biosciences' mental illness course pivot has actually neglected. The biotech was actuall...

Sanofi spends $110M upfront for late-stage radioligand treatment

.Sanofi has actually created a late access to the radioligand event, paying out 100 thousand europea...